Thursday, December 19, 2024
HomeTagsHepatocellular

Hepatocellular

Lion TCR Receives FDA Fast Track Designation for its HBV-specific TCR T Cell Therapy for Hepatocellular Carcinoma

Lion TCR Pte Ltd  announced that it has received Fast Track Designation from United States Food and Drug Administration (U.S. FDA) for LioCyx-M004, autologous...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics